How were Digirad's earnings last quarter?

Digirad Co. (NASDAQ:DRAD) posted its earnings results on Wednesday, November, 18th. The medical equipment provider reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of $0.15 by $0.34. The medical equipment provider earned $30.35 million during the quarter. Digirad had a negative trailing twelve-month return on equity of 3.75% and a negative net margin of 5.32%.

Is Digirad a good dividend stock?

Digirad (NASDAQ:DRAD) pays an annual dividend of $2.20 per share and currently has a dividend yield of 83.65%. DRAD has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for DRAD .

When did Digirad's stock split?

Shares of Digirad reverse split before market open on Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What is Matt Molchan's approval rating as Digirad's CEO?

26 employees have rated Digirad Chief Executive Officer Matt Molchan on Glassdoor.com . Matt Molchan has an approval rating of 70% among the company's employees. 57.0% of employees surveyed would recommend working at Digirad to a friend.

What other stocks do shareholders of Digirad own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Digirad investors own include Gilead Sciences (GILD) , AT&T (T) , Exelixis (EXEL) , Enphase Energy (ENPH) , OPKO Health (OPK) , Rigel Pharmaceuticals (RIGL) , AcelRx Pharmaceuticals (ACRX) , Amyris (AMRS) , General Electric (GE) and Genocea Biosciences (GNCA) .

NASDAQ:DRAD

Digirad (DRAD) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free DRAD Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.85
▼
$0.88
50-Day Range: $2.79
▼
$4.65
52-Week Range: $1.99
▼
$8.84

Volume: 9,293 shs
Average Volume: 485,592 shs
Market Capitalization: $4.05 million

P/E Ratio: N/A
Dividend Yield: 258.67%
Price Target: N/A

Stock Analysis Competitors Social Media

Get Digirad alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Digirad Stock (NASDAQ:DRAD)

Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.

Ad Crypto 101 Media

SHOCKING Crypto Leak…

Claim your free seat by clicking here now.

DRAD Stock News Headlines

January 7, 2024 | nasdaq.com

April 19th Options Now Available For Karuna Therapeutics (KRTX)

May 20, 2023 | cbsnews.com

2 girls dead, 1 hospitalized after possible overdoses at high school

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

April 23, 2023 | usatoday.com

Connecticut teachers thought 5-year-old boy was just 'playing dead' before he died, lawsuit claims

January 16, 2023 | nypost.com

Lisa Marie Presley dead at 54 after cardiac arrest: ‘My beautiful daughter’

January 14, 2023 | foxnews.com

Rock icon Jeff Beck dead at 78

October 12, 2022 | businesswire.com

Global Nuclear Medicine Equipment Market Report to 2030 - Featuring Siemens Healthineers, Fujifilm Holdings, Canon and Digirad Among Others - ResearchAndMarkets.com - Business Wire

October 11, 2022 | finance.yahoo.com

Global Single Photon Emission Computed Tomography (SPECT) Market to Reach $2.7 Billion by 2027 - Yahoo Finance

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

October 10, 2022 | prnewswire.com

3D Vascular Ultrasound Imaging Market to record USD 344.17 Mn incremental growth; North America to have a significant share -- Technavio - PR Newswire

October 7, 2022 | finance.yahoo.com

Outlook on the Nuclear Medicine Equipment Global Market to 2030 - Rising Adoption of Nuclear Medicine Equipment and Emergence of Innovative & Advanced Equipment is Driving Growth - Yahoo Finance

August 26, 2022 | benzinga.com

Global Single Photon Emission Computed Tomography (SPECT) Market Report 2022-2026: Hybrid SPECT Systems W - Benzinga

August 25, 2022 | finance.yahoo.com

Global Single Photon Emission Computed Tomography (SPECT) Market Report 2022: Market to Reach $2.5 Billion by 2026 - SPECT Dominates the Nuclear Medicine Market - Yahoo Finance

August 17, 2022 | streetinsider.com

MD Office Solutions, LLC, acquires Antigua Medical Services, LLC; a Cardiac Mobile Imaging Company in Arizona - StreetInsider.com

August 12, 2022 | seekingalpha.com

Star Equity Holdings, Inc. (STRR) CEO Rick Coleman on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

July 19, 2022 | businesswire.com

Global Mobile Medical Imaging Services Market Report (2022 to 2027) - Transition of Diagnostic Image Processing Techniques from 2D to 3D Presents Opportunities - ResearchAndMarkets.com - Business Wire

July 16, 2022 | streetinsider.com

Form 10-K SOLITRON DEVICES INC For: Feb 28 - StreetInsider.com

June 9, 2022 | benzinga.com

Global Mobile Imaging Services Market Report 2022-2026: Rise of Home Healthcare - The Cornerstone for the - Benzinga

June 9, 2022 | globenewswire.com

Nuclear Medicine Equipment Market is projected to record a CAGR of 4.1%, during 2022 - 2032 : Future Market Insights, Inc. - GlobeNewswire

April 29, 2022 | streetinsider.com

Form 10-K/A CNS Pharmaceuticals, For: Dec 31 - StreetInsider.com

April 22, 2022 | streetinsider.com

Form 8-K STAR EQUITY HOLDINGS, For: Apr 19 - StreetInsider.com

April 8, 2022 | financialpost.com

Nuclear Imaging Equipment Market worth $3.4 billion by 2025- Exclusive Report by MarketsandMarkets™ - Financial Post

March 22, 2022 | seekingalpha.com

Star Equity Holdings, Inc. (STRR) Management on Q4 2021 Results - Earnings Call Transcript - Seeking Alpha

March 9, 2022 | prnewswire.com

3D Medical Imaging Services Market to Reach $377.06 Bn, Globally, by 2030 at 6.6% CAGR: Allied Market Research - PR Newswire

February 21, 2022 | msn.com

Who's Hiring In The Cumming Area? See New Local Jobs - Reverb MSN Music

January 18, 2022 | businesswire.com

Foldax Appoints Scott Huennekens to Board of Directors - Business Wire

January 13, 2022 | gurufocus.com

Star Equity Holdings, Inc. Iss - GuruFocus.com

See More Headlines

Receive DRAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Digirad and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/18/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical Equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:DRAD
CUSIP: N/A
CIK: 707388
Web: www.digirad.com
Phone: 858-726-1600
Fax: N/A
Employees: 618
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.35)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,630,000.00
Net Margins: -5.32%
Pretax Margin: N/A
Return on Equity: -3.75%
Return on Assets: -0.85%

Debt

Debt-to-Equity Ratio: 0.88
Current Ratio: 1.27
Quick Ratio: 0.91

Sales & Book Value

Annual Sales: $114.18 million
Price / Sales: 0.04
Cash Flow: $1.23 per share
Price / Cash Flow: 0.69
Book Value: $10.30 per share
Price / Book: 0.08

Miscellaneous

Outstanding Shares: 4,760,000
Free Float: N/A
Market Cap: $4.05 million
Optionable: Not Optionable
Beta: 0.18

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Matthew Gabel Molchan (Age 53)
Pres, CEO & Director
Comp: $705.96k
Mr. David James Noble (Age 50)
CFO & COO
Comp: $495.77k
Mr. Martin B. Shirley (Age 58)
Pres of Digirad Imaging Solutions
Comp: $427.94k
Ms. Hannah Bible
VP of Legal & Fin.
Mr. Bob Halbert
Sr. Director of Human Resource

Key Competitors

View All Competitors

DRAD Stock Analysis - Frequently Asked Questions

How were Digirad's earnings last quarter?: Digirad Co. (NASDAQ:DRAD) posted its earnings results on Wednesday, November, 18th. The medical equipment provider reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of $0.15 by $0.34. The medical equipment provider earned $30.35 million during the quarter. Digirad had a negative trailing twelve-month return on equity of 3.75% and a negative net margin of 5.32%.
Is Digirad a good dividend stock?: Digirad (NASDAQ:DRAD) pays an annual dividend of $2.20 per share and currently has a dividend yield of 83.65%. DRAD has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for DRAD.
When did Digirad's stock split?: Shares of Digirad reverse split before market open on Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What is Matt Molchan's approval rating as Digirad's CEO?: 26 employees have rated Digirad Chief Executive Officer Matt Molchan on Glassdoor.com. Matt Molchan has an approval rating of 70% among the company's employees. 57.0% of employees surveyed would recommend working at Digirad to a friend.
What other stocks do shareholders of Digirad own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Digirad investors own include Gilead Sciences (GILD), AT&T (T), Exelixis (EXEL), Enphase Energy (ENPH), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), AcelRx Pharmaceuticals (ACRX), Amyris (AMRS), General Electric (GE) and Genocea Biosciences (GNCA).

This page (NASDAQ:DRAD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Digirad (DRAD) Stock Price, News & Analysis

About Digirad Stock (NASDAQ:DRAD)

DRAD Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

DRAD Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info